887 related articles for article (PubMed ID: 16184515)
1. Induction of central T cell tolerance: recombinant antibodies deliver peptides for deletion of antigen-specific (CD4+)8+ thymocytes.
Schjetne KW; Thommesen JE; Fredriksen AB; Lunde E; Sandlie I; Bogen B
Eur J Immunol; 2005 Nov; 35(11):3142-52. PubMed ID: 16184515
[TBL] [Abstract][Full Text] [Related]
2. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P
J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002
[TBL] [Abstract][Full Text] [Related]
3. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
[TBL] [Abstract][Full Text] [Related]
4. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.
Schurmans S; Brighouse G; Kramer G; Wen L; Izui S; Merino J; Lambert PH
J Immunol; 1991 Apr; 146(7):2152-60. PubMed ID: 1672344
[TBL] [Abstract][Full Text] [Related]
5. Deletion of alloantigen-reactive thymocytes as a mechanism of adult tolerance induction following intrathymic antigen administration.
Jones ND; Fluck NC; Roelen DL; Mellor AL; Morris PJ; Wood KJ
Eur J Immunol; 1997 Jul; 27(7):1591-600. PubMed ID: 9247566
[TBL] [Abstract][Full Text] [Related]
6. Thymocyte antigens do not induce tolerance in the CD4+ T cell compartment.
Jhaver KG; Chandler P; Simpson E; Mellor AL
J Immunol; 1999 Nov; 163(9):4851-8. PubMed ID: 10528186
[TBL] [Abstract][Full Text] [Related]
7. Efficient delivery of T cell epitopes to APC by use of MHC class II-specific Troybodies.
Lunde E; Western KH; Rasmussen IB; Sandlie I; Bogen B
J Immunol; 2002 Mar; 168(5):2154-62. PubMed ID: 11859101
[TBL] [Abstract][Full Text] [Related]
8. Weak positive selection of transgenic T cell receptor-bearing thymocytes: importance of major histocompatibility complex class II, T cell receptor and CD4 surface molecule densities.
Bogen B; Gleditsch L; Weiss S; Dembic Z
Eur J Immunol; 1992 Mar; 22(3):703-9. PubMed ID: 1547816
[TBL] [Abstract][Full Text] [Related]
9. Clonal deletion of major histocompatibility complex class I-restricted CD4+CD8+ thymocytes in vitro is independent of the CD95 (APO-1/Fas) ligand.
Müller KP; Mariani SM; Matiba B; Kyewski B; Krammer PH
Eur J Immunol; 1995 Oct; 25(10):2996-9. PubMed ID: 7589104
[TBL] [Abstract][Full Text] [Related]
10. Cutting edge: negative selection of immature thymocytes by a few peptide-MHC complexes: differential sensitivity of immature and mature T cells.
Peterson DA; DiPaolo RJ; Kanagawa O; Unanue ER
J Immunol; 1999 Mar; 162(6):3117-20. PubMed ID: 10092759
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of I-Ad-, but not Db-restricted peptide-induced thymic apoptosis by glucocorticoid receptor antagonist RU486 in T cell receptor transgenic mice.
Xue Y; Murdjeva M; Okret S; McConkey D; Kiuossis D; Jondal M
Eur J Immunol; 1996 Feb; 26(2):428-34. PubMed ID: 8617314
[TBL] [Abstract][Full Text] [Related]
12. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant.
Kanagawa O; Vaupel BA; Xu G; Unanue ER; Katz JD
J Immunol; 1998 Nov; 161(9):4489-92. PubMed ID: 9794372
[TBL] [Abstract][Full Text] [Related]
13. Human CD14 is an efficient target for recombinant immunoglobulin vaccine constructs that deliver T cell epitopes.
Tunheim G; Schjetne KW; Fredriksen AB; Sandlie I; Bogen B
J Leukoc Biol; 2005 Mar; 77(3):303-10. PubMed ID: 15576418
[TBL] [Abstract][Full Text] [Related]
14. Peripheral T cell tolerance as a tumor escape mechanism: deletion of CD4+ T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytoma.
Bogen B
Eur J Immunol; 1996 Nov; 26(11):2671-9. PubMed ID: 8921954
[TBL] [Abstract][Full Text] [Related]
15. Clonal deletion of immature CD4+8+ thymocytes in suspension culture by extrathymic antigen-presenting cells.
Swat W; Ignatowicz L; von Boehmer H; Kisielow P
Nature; 1991 May; 351(6322):150-3. PubMed ID: 1903182
[TBL] [Abstract][Full Text] [Related]
16. Central T cell tolerance in lupus-prone mice: influence of autoimmune background and the lpr mutation.
Fatenejad S; Peng SL; Disorbo O; Craft J
J Immunol; 1998 Dec; 161(11):6427-32. PubMed ID: 9834135
[TBL] [Abstract][Full Text] [Related]
17. Unexpected reactivities of T cells selected by a single MHC-peptide ligand.
Singh N; Van Kaer L
J Immunol; 1999 Oct; 163(7):3583-91. PubMed ID: 10490950
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of clonal deletion vs. anergy of self-reactive CD4 T-cells for the prevention and reversal of autoimmune diabetes.
Preda-Pais A; Stan AC; Casares S; Bona C; Brumeanu TD
J Autoimmun; 2005 Aug; 25(1):21-32. PubMed ID: 16005609
[TBL] [Abstract][Full Text] [Related]
19. In vivo mechanisms of acquired thymic tolerance.
Chen W; Issazadeh S; Sayegh MH; Khoury SJ
Cell Immunol; 1997 Aug; 179(2):165-73. PubMed ID: 9268500
[TBL] [Abstract][Full Text] [Related]
20. Selection of aberrant class II restricted CD8+ T cells in NOD mice expressing a glutamic acid decarboxylase (GAD)65-specific T cell receptor transgene.
Ranheim EA; Tarbell KV; Krogsgaard M; Mallet-Designe V; Teyton L; McDevitt HO; Weissman IL
Autoimmunity; 2004 Dec; 37(8):555-67. PubMed ID: 15763918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
